Precision BioSciences Expands Patent War Against Cellectis

Law360, New York (March 13, 2012, 3:54 PM EDT) -- The ink didn't have a chance to dry on a newly obtained genome engineering technology patent before Precision BioSciences Inc. lodged its sixth patent infringement suit against rival Cellectis SA in North Carolina on Tuesday.

Precision BioSciences' newest complaint alleges Cellectis and its affiliates violated a patent that was issued by the U.S. Patent and Trademark Office on Tuesday.

“Cellectis, Cellectis bioresearch and Cellectis bioresearch USA have been and are making, using, selling, offering for sale and/or importing into the United States [products] for use in...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.